26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

arcitumomab 77 Arthus, Nicolas Maurice (1862–1945)<br />

uptake, and enhanced binding to endothelial cells. It can cause<br />

cation fluxes, augment cytoplasmic calcium concentrations,<br />

form intracellular pools, and activate phosphatidylinositol<br />

hydrolysis. LTB 4 can act synergistically with prostaglandins<br />

E 1 (PGE 1) and PGE 2 to induce macromolecule leakage in the<br />

skin through increased vascular permeability. When injected<br />

into the skin of a guinea pig, it can induce leukocytoclastic<br />

vasculitis. Human polymorphonuclear neutrophils have two<br />

sets of plasma membrane receptors. A high affinity receptor<br />

set mediates aggregation, chemokinesis, and increased surface<br />

adherence, whereas the low affinity receptor set mediates<br />

degranulation and increased oxidative metabolism. A fraction<br />

of CD4 + and CD8 + T lymphocytes bind LTB 4, but LTB 4 receptors<br />

on lymphocytes remain to be characterized.<br />

arcitumomab<br />

A murine F(ab′) 2 fragment of an anti-carcinoembryonic<br />

antigen (CEA) antibody labeled with technetium 99m<br />

( 99m Tc) used for imaging patients with metastatic colorectal<br />

cancer by immunoscintigraphy to evaluate spread of the<br />

disease. Use of the F(ab′) 2 fragment diminishes the immunogenicity,<br />

permitting it to be used more than once.<br />

arenavirus immunity<br />

Even though arenaviruses may not cause ill effects in carrier<br />

rodents, when transmitted to primates they may induce<br />

severe encephalitis, hepatitis, or hemorrhagic syndrome.<br />

LCMV is a classic member of this group and has been<br />

used to investigate virus-induced, cell-mediated immunity.<br />

Infection of mice may be either acute (inducing strong<br />

cell-mediated immunity) or persistent (associated with little<br />

cell-mediated immunity). The immune response to the acute<br />

infection either kills the mouse by causing meningitis or subsides<br />

and renders the mouse LCMV-immune. CD8+ T cells<br />

clear the virus infection and may also mediate pathological<br />

changes of choriomeningitis when injected intracerebrally.<br />

LCMV infection induces interferon γ (IFN-γ) and tumor<br />

necrosis factor α, which affect host immune responses.<br />

IFN-γ induces natural killer (NK) cell proliferation, which<br />

eliminates pathogen-infected cells and selected tumors.<br />

Arenaviruses persist in long-term carriers through antigenic<br />

variation that evades the host immune response. Mice may be<br />

protected from lethal LCMV challenge by peptide vaccination<br />

or by vaccinia vectors that express viral epitopes.<br />

arginine and immunity<br />

Arginine, a dibasic nitrogen-rich amino acid, has a marked<br />

immunomodulatory function. It is critical for the maintenance<br />

of nitrogen balance and physiologic functions in humans.<br />

Supplemental administration of arginine in experimental<br />

animals led to increased thymic size, lymphocyte count, and<br />

lymphocyte mitogenic response to mitogens and antigens. IL-2<br />

synthesis is enhanced. Arginine protects against post-traumatic<br />

thymic involution and the impairment of T cell function.<br />

It enhances delayed-type hypersensitivity reactions in animal<br />

studies and also promotes host antitumor responses. Arginine<br />

is essential for the functions of various immunoregulatory proteins<br />

including thymosin, thymopentin, and tuftsin. Arginine<br />

exerts powerful effects on numerous cells and molecules of the<br />

immune system and may have potential as a pharmacologic<br />

agent in the treatment of immunocompromised patients.<br />

Arlacel A ®<br />

A mannide monooleate used as an emulsifier to stabilize<br />

water-in-oil emulsions employed as adjuvants (e.g., Freund’s<br />

adjuvant) in experimental immunology.<br />

armed cytotoxic T lymphocyte (armed CTL)<br />

A mature effector cytotoxic T lymphocyte that forms<br />

chemical mediators prior to contact with antigen that will<br />

be employed to fatally injure target cells with which they<br />

come into contact.<br />

armed effector T cells<br />

Activated effector T cells induced to mediate their effector<br />

functions as soon as they contact cells expressing the peptide–major<br />

histocompatability complex (MHC) for which<br />

they are specific. By contrast, memory T lymphocytes<br />

require activation by antigen-presenting cells to empower<br />

them to carry out effector functions.<br />

armed macrophages<br />

Macrophages bearing surface immunoglobulin G (IgG) or<br />

IgM cytophilic antibodies or T cell lymphokines that render<br />

them capable of inducing antigen-specific cytotoxicity.<br />

Svante Arrhenius (left) and Paul Ehrlich (right).<br />

armed mast cell<br />

A mast cell whose Fcε receptors have bound IgE molecules<br />

specific for antigen prior to interaction with that same allergen.<br />

Arrhenius, Svante (1859–1927)<br />

Arrhenius coined the immunochemistry term and hypothesized<br />

that antigen–antibody complexes are reversible. He<br />

was awarded the Nobel Prize for chemistry in 1903. (See<br />

Arrhenius, S., Immunochemistry, Macmillan Publishers,<br />

New York, 1907).<br />

Artemis SCID<br />

A form of severe combined immunodeficiency attributable<br />

to mutations of the Artemis gene that codes for a factor<br />

significant in both V(D)J recombination and DNA repair.<br />

arthritis<br />

Joint inflammation.<br />

Arthus, Nicolas Maurice (1862–1945)<br />

Paris physician who studied venoms and their physiological<br />

effects; first to describe local anaphylaxis or the Arthus reaction<br />

(1903). Author of De l’Anaphylaxie a l’Immunite, 1921.<br />

A

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!